文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Chana Fuchs
发表
Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer.
Richard Pazdur, Huanyu Chen, P. Keegan, 2013, The oncologist.